Drug Type AAV based gene therapy |
Synonyms JWK 004 |
Target |
Mechanism factor IX modulators(Coagulation factor IX modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hemophilia B | Preclinical | CN | 16 Mar 2022 |